期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

2007年ASCO会议小细胞肺癌治疗研究进展 被引量：1

The advance of the treatment of small- cell lung cancer in 2007 ASCO Annual Meeting
原文传递
导出
摘要 综述2007年ASCO会议上小细胞肺癌外科手术的地位与作用、预防性全脑照射、一线化疗、二线化疗及靶向治疗等的研究进展。 This article reviews the advance of the treatment of small-cell lung cancer in 2007 ASCO Annual Meeting in aspects such as the surgey as primary treatment for small cell lung cancer, prophylactic cranial irradiation, first-line chemotherapy, second-line chemotherapy and target therapy.
作者 卢红阳（综述） 马胜林（审校） 蔡菊芬（审校）
机构地区 浙江省肿瘤医院化疗中心
出处 《国际肿瘤学杂志》 CAS 2007年第11期866-869,共4页 Journal of International Oncology
关键词 癌 小细胞 肺肿瘤 药物疗法 抗体 单克隆 Carcinoma, small cell Lung neoplasms Drug therapy Antibodies, monoclonal
分类号 R734.2 [医药卫生—肿瘤]
  • 相关文献

参考文献19

  • 1Lira E, Goldstraw P. Surgery as primary treatment for limited disease small cell lung cancer: Time to re-evaluate. Proc Am Soc Clin Oncol, 2007, 25 (18S) :7719. 被引量：1
  • 2Slotman B, Faivre-Finn C, Kramer G, et al. A randomized trial of prophylactic cranial irradiation (PCI) versus no PCI in extensive disease small cell lung cancer after a response to chemotherapy ( EORTC 08993-22993 ). Proc Am Soc Clin Oncol, 2007, 25 (18S) :4. 被引量：1
  • 3Uyeki J, Johnson FM, Feng L, et al. Phase Ⅱ trial of irinotecan plus eisplatin (IP) and etoposide plus eisplatin (EP) given weekly on alternating weeks with granulocyte colony-stimulatiog factor support in the treatment of extensive-stage small cell lung cancer. Proc Am Soc Clin Oncol, 2007, 25 (18S) : 18119. 被引量：1
  • 4Syrlgos K, Katirtzoglou N, Charpidou A, et al. Irinotecan, carboplatin and etoposide regimen in extensive disease small cell lung cancer: Phase Ⅱ trial. Proc Am Soc Clin Oncol, 2007, 25(18S) :18153. 被引量：1
  • 5Lee JS, Han J, Yu S, et al. The progress of small cell lung cancer management using irinotecan plus cisplatin chemotherapy. Proc Am Soc Clin Oncol, 2007, 25 (18S):7721. 被引量：1
  • 6Lee G, Kim K, Cho Y, et al. Combination chemotherapy with irinotecan and cisplatin in elderly patients ( ≥65 yeats) with extensive-disease small-cell lung cancer. Proc Am Soc Clin Oncol, 2007, 25 (18S) :18135. 被引量：1
  • 7Hermes A, Be~man B, BremnesR, et al. A randomized phase Ⅲ trial of irinolecan plus carboplatin versus etoposide plus carboplatin in patients with small cell lung cancer, extensive disease (SCLC-ED) : 1-RIS-Study. Proc Am Soc Clin Oncol, 2007, 25(18S) :7523. 被引量：1
  • 8Jotte RM, Reynolds CH, Conkling P, et al. randomized phase 2 trial of amrubicin compared to topotecan as second-line treatments in extensive disease small cell lung cancer (SCLC) sensitive to platinum-based first-line chemotherapy. Proc Am Soc Clin Oncol, 2007, 25 (18S) : 18064. 被引量：1
  • 9Choi H, Choi B, Shin S, et al. Topotecan and etoposide as salvage chemotherapy in patients with irinotecan-and platinum-failed small-cell lung cancer: A phase Ⅱ study. Proc Am Soe Clin Oncol, 2007, 25 (18S) :18177. 被引量：1
  • 10Peyton JD, Spigel DR, Hainsworth JD, et al. Phase Ⅱ trial of vinflunine in patients with relapsed small cell lung cancer. Proe Am Soc Clin Oncol, 2007, 25 (18S) : 18091. 被引量：1

同被引文献2

引证文献1

国际肿瘤学杂志
2007年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部